Biogen Idec
General Information
Identification Code: 119994349753-01
Website: https://www.biogen.com/
Entity Form: Corporation
Registration Category: Companies & groups
Registration Date: 4/11/2023
Last Update: 4/4/2024
Mission & Interests
Goals: Founded in 1978, Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patient’s lives and to create value for shareholders and our communities. We apply deep understanding of human biology and leverage different modalities to advance first-in-class treatments or therapies that deliver superior outcomes. Our approach is to take bold risks, balanced with return on investment to deliver long-term growth.
Interests Represented: Promotes their own interests or the collective interests of their members
Interests:
- Budget
- Business and industry
- Competition
- Consumers
- Customs
- Digital economy and society
- Economy, finance and the euro
- Employment and social affairs
- Environment
- Institutional affairs
- Public health
- Research and innovation
- Single market
- Trade
Levels of Interest:
- european
- global
- national
Activities
Main EU Legislative Proposals: European Pharmaceutical Strategy; EU’s Intellectual Property framework; Orphan Medicinal Products Regulation; Industrial Strategy; Biosimilars & generics; EU Relative Efficacy Assessment and Health Technology Assessment; Digital framework and e-health topics; Patient access to innovation; Competition in the Pharmaceutical Sector; Non-Communicable Diseases; Rare Diseases; Demographic Change and healthy ageing, with a focus on Alzheimer’s disease; Mental and Brain Health.
Inter-institutional or Unofficial Groupings: N/A
Head Office
Address: 225 Binney Street
Post Code: MA 02142
City: Cambridge
Country: UNITED STATES
Phone:
Indic Phone: 32
Phone Number: 478016945
EU Office
Address: Park Lane, Culliganlaan 2G
Post Code: 1831
City: Diegem
Country: BELGIUM
Phone:
Indic Phone: 32
Phone Number: 478016945
Financial Data
Closed Year:
Start Date:
End Date:
Funding Sources:
Contributions:
Total Budget: 0
Grants:
Current Year:
Grants:
Membership Information
Members10 Percent: 2
Members25 Percent: 1
Members50 Percent: 1
Members: 4
Members F T E: 0.949999988079071
Info Members: Please note that Biogen contributed to a number of EU consultations under its previous Registry number 966165310889-60:
List of contributions to public consultations:
• Revision of the EU general pharmaceuticals legislation Revision of the EU general pharmaceuticals legislation
• Revision of the EU legislation on medicines for children and rare diseases Medicines for children & rare diseases – updated rules
• Pharmaceutical Strategy - Timely patient access to affordable medicines Pharmaceuticals – safe and affordable medicines (new EU strategy)
• Digital health data and services – the European health data space
List of contributions to roadmaps:
• Pharmaceuticals – safe and affordable medicines (new EU strategy)
• Revision of the EU general pharmaceuticals legislation
• Digital health data and services – the European health data space
Structure
Structure Type: Structure
Is Member Of: Orphan Drug Expert Group (https://od-expertgroup.eu/about-us/)
The Global CEO Initiative on Alzheimer's Disease (https://www.usagainstalzheimers.org/our-enterprise/CEOi)
Organisation Members: Biogen is a member of the following organisations:
EFPIA – European Federation of Pharmaceutical Industries and Associations (https://efpia.eu/)
Eucope – European Confederation of Pharmaceutical Entrepreneurs (https://www.eucope.org/)
MFE – Medicines for Europe (https://www.medicinesforeurope.com/)
Current Job Opportunities
Officer - Companies & groups at Biogen Idec
Biogen Idec
juniorBrussels, BelgiumFull-time-time
Posted: 10/16/2025